Literature DB >> 21836069

Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice.

Hong Feng1, Ling Guo, Dan Wang, Haiqing Gao, Guihua Hou, Zhong Zheng, Junting Ai, Oded Foreman, Alan Daugherty, Xiang-An Li.   

Abstract

OBJECTIVE: Scavenger receptor BI (SR-BI) is a high-density lipoprotein (HDL) receptor. Recent studies revealed that SR-BI protects against sepsis via modulating innate immunity. However, its role in adaptive immunity is unclear. METHODS AND
RESULTS: SR-BI-null mice exhibited impaired lymphocyte homeostasis as shown by splenomegaly and imbalanced expansion of T and B lymphocytes in the spleens. Importantly, the activated T and B lymphocytes were increased 3- to 4-fold, indicating a heightened active status of T and B lymphocytes. More importantly, in line with the accumulation of the activated T and B lymphocytes, SR-BI-null mice developed systemic autoimmune disorders characterized by the presence of autoantibodies in circulation, the deposition of immune complexes in glomeruli, and the leukocyte infiltration in kidney. Further analyses revealed that SR-BI deficiency enhanced lymphocyte proliferation, caused imbalanced interferon-γ and interleukin-4 production in lymphocytes, and caused elevated inflammatory cytokine production in macrophages. Furthermore, HDL from SR-BI-null mice exhibited less capability of suppressing lymphocyte proliferation.
CONCLUSION: SR-BI regulates lymphocyte homeostasis, likely through its roles in modulating the proliferation of lymphocytes, the cytokine production by lymphocytes and macrophages, and the function of HDL. Its deficiency leads to impaired lymphocyte homeostasis and autoimmune disorders. Our findings reveal a previously unrecognized role of SR-BI in adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21836069      PMCID: PMC3202973          DOI: 10.1161/ATVBAHA.111.234716

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

1.  Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI.

Authors:  Teresa M Holm; Anne Braun; Bernardo L Trigatti; Carlo Brugnara; Masa Sakamoto; Monty Krieger; Nancy C Andrews
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

2.  High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.

Authors:  I S Yuhanna; Y Zhu; B E Cox; L D Hahner; S Osborne-Lawrence; P Lu; Y L Marcel; R G Anderson; M E Mendelsohn; H H Hobbs; P W Shaul
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

3.  Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

Authors:  J H Morse; L D Witte; D S Goodman
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

4.  Scavenger receptor SR-BI in macrophage lipid metabolism.

Authors:  Ailing Ji; Jason M Meyer; Lei Cai; Akinwunmi Akinmusire; Maria C de Beer; Nancy R Webb; Deneys R van der Westhuyzen
Journal:  Atherosclerosis       Date:  2011-04-09       Impact factor: 5.162

5.  High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner.

Authors:  Xiang-An Li; William B Titlow; Brian A Jackson; Nathalia Giltiay; Mariana Nikolova-Karakashian; Annette Uittenbogaard; Eric J Smart
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

6.  Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice.

Authors:  Anne Braun; Bernardo L Trigatti; Mark J Post; Kaori Sato; Michael Simons; Jay M Edelberg; Robert D Rosenberg; Mark Schrenzel; Monty Krieger
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

7.  HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.

Authors:  Ming Gong; Melinda Wilson; Thomas Kelly; Wen Su; James Dressman; Jeanie Kincer; Sergey V Matveev; Ling Guo; Theresa Guerin; Xiang-An Li; Weifei Zhu; Annette Uittenbogaard; Eric J Smart
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

8.  Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse.

Authors:  K F Kozarsky; M H Donahee; J M Glick; M Krieger; D J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

9.  High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases.

Authors:  Chieko Mineo; Ivan S Yuhanna; Michael J Quon; Philip W Shaul
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

10.  Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver.

Authors:  Miranda Van Eck; Jaap Twisk; Menno Hoekstra; Brechje T Van Rij; Christian A C Van der Lans; I Sophie T Bos; J Kar Kruijt; Folkert Kuipers; Theo J C Van Berkel
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

View more
  31 in total

Review 1.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

2.  Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsis.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Deborah A Howatt; Paul R Mittelstadt; Seth Thacker; Alan Daugherty; Jonathan D Ashwell; Alan T Remaley; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-06       Impact factor: 8.311

3.  Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.

Authors:  Leland L Black; Roshni Srivastava; Trenton R Schoeb; Ray D Moore; Stephen Barnes; Janusz H Kabarowski
Journal:  J Immunol       Date:  2015-10-14       Impact factor: 5.422

Review 4.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

Review 5.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

6.  Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

7.  The atherogenic Scarb1 null mouse model shows a high bone mass phenotype.

Authors:  Corine Martineau; Louise Martin-Falstrault; Louise Brissette; Robert Moreau
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-19       Impact factor: 4.310

8.  Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness.

Authors:  Xingwen Wang; Changshun Wu; Baoying Yuan; Dan Wang; Huiling Liu; Hong Feng; Shui Sun
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

9.  SR-BI (Scavenger Receptor Class B Type 1) Is Critical in Maintaining Normal T-Cell Development and Enhancing Thymic Regeneration.

Authors:  Zhong Zheng; Junting Ai; Ling Guo; Xiang Ye; Subbarao Bondada; Deborah Howatt; Alan Daugherty; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

10.  Human SR-BI and SR-BII Potentiate Lipopolysaccharide-Induced Inflammation and Acute Liver and Kidney Injury in Mice.

Authors:  Irina N Baranova; Ana C P Souza; Alexander V Bocharov; Tatyana G Vishnyakova; Xuzhen Hu; Boris L Vaisman; Marcelo J Amar; Zhigang Chen; Yana Kost; Alan T Remaley; Amy P Patterson; Peter S T Yuen; Robert A Star; Thomas L Eggerman
Journal:  J Immunol       Date:  2016-03-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.